Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 16-18 June 2020 19 June 2020Press releaseVeterinaryMedicinesVaccines International regulators stress value of safe and effective vaccines 18 June 2020Press releaseHuman Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 – update #4 15 June 2020NewsHumanCOVID-19Clinical trials Annual report 2019 published 15 June 2020NewsCorporate Highlights of Management Board: June 2020 meeting 12 June 2020Press releaseCorporateCOVID-19Clinical trialsGovernance Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 June 2020 12 June 2020NewsHumanPharmacovigilanceReferrals Latest data support continued use of ACE inhibitors and ARB medicines during COVID-19 pandemic 9 June 2020Press releaseHumanCOVID-19MedicinesResearch and development EU actions to support availability of medicines during COVID-19 pandemic – update #7 8 June 2020Press releaseHumanVeterinaryCOVID-19Medicine shortages EMA receives application for conditional authorisation of first COVID-19 treatment in the EU 8 June 2020Press releaseHumanCOVID-19Medicines Patients’ and healthcare professionals’ organisations updated on EMA’s response to COVID-19 4 June 2020NewsHumanCOVID-19 1 … 80 81 82 83 84 Page 84 of 380 85 86 87 88 … 380
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 16-18 June 2020 19 June 2020Press releaseVeterinaryMedicinesVaccines
Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 – update #4 15 June 2020NewsHumanCOVID-19Clinical trials
Highlights of Management Board: June 2020 meeting 12 June 2020Press releaseCorporateCOVID-19Clinical trialsGovernance
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 June 2020 12 June 2020NewsHumanPharmacovigilanceReferrals
Latest data support continued use of ACE inhibitors and ARB medicines during COVID-19 pandemic 9 June 2020Press releaseHumanCOVID-19MedicinesResearch and development
EU actions to support availability of medicines during COVID-19 pandemic – update #7 8 June 2020Press releaseHumanVeterinaryCOVID-19Medicine shortages
EMA receives application for conditional authorisation of first COVID-19 treatment in the EU 8 June 2020Press releaseHumanCOVID-19Medicines
Patients’ and healthcare professionals’ organisations updated on EMA’s response to COVID-19 4 June 2020NewsHumanCOVID-19